Konturek P C, Brzozowski T, Sliwowski Z, Pajdo R, Stachura J, Hahn E G, Konturek S J
Dept. of Medicine I, University of Medicine, Erlangen-Nuremberg, Nuremberg, Germany.
Scand J Gastroenterol. 1998 Jul;33(7):691-700. doi: 10.1080/00365529850171611.
Lipopolysaccharide (LPS) has been proposed to act as one of the pathogens in endotoxemia-induced gastric lesions, but its action on mucosal integrity has not been fully clarified.
We compared the effects of LPS originating from Escherichia coli and the chemical donor of nitric oxide (NO), S-nitroso-acetylpenicillamine (SNAP), on acute gastric lesions induced by 100% ethanol, mucosal blood flow (GBF), and mucosal generation of prostaglandin E2 (PGE2) and examined the expression of constitutive NO synthase (cNOS) and inducible NO synthase (iNOS) mRNA in the gastric mucosa of rats treated with LPS, by using reverse transcription polymerase chain reaction (RT-PCR).
LPS (0.01-1.0 mg/kg) or SNAP (0.37-3.0 mg/kg) given intraperitoneally, dose-dependently prevented ethanol-induced mucosal lesions, and these protective effects were accompanied by a significant increase in the GBF and excessive mucosal release of NO. Suppression of NOS activity by NG-nitro-L-arginine methyl ester (L-NAME) (20mg/kg intravenously) or L-NG-(1-iminoethyl)-lysine (L-NIL) (30mg/kg intraperitoneally) and NOS induction by treatment with dexamethasone (2 mg/kg intraperitoneally) reversed the protective and hyperemic effects of LPS, and this reversal by L-NAME was significantly antagonized by addition of the substrate for NOS, L-arginine, but not D-arginine. Both LPS and SNAP increased PGE2 generation significantly, and this effect was reduced by pretreatment with L-NAME, L-NIL, or dexamethasone. Expression of cNOS was detected by RT-PCR in the intact mucosa, but intense signals for expression of both cNOS and iNOS were detected in the mucosa of LPS-treated rats.
Parenteral LPS, similarly to the chemical NO donor, SNAP, protects the gastric mucosa against ethanol-induced damage via an increase in GBF mediated by NO due to the activation of arginine-NO system and possibly also enhanced generation of PGE2.
脂多糖(LPS)被认为是内毒素血症诱导的胃损伤的病原体之一,但其对黏膜完整性的作用尚未完全阐明。
我们比较了源自大肠杆菌的LPS和一氧化氮(NO)的化学供体S-亚硝基乙酰青霉胺(SNAP)对100%乙醇诱导的急性胃损伤、黏膜血流量(GBF)以及黏膜前列腺素E2(PGE2)生成的影响,并通过逆转录聚合酶链反应(RT-PCR)检测了LPS处理的大鼠胃黏膜中组成型一氧化氮合酶(cNOS)和诱导型一氧化氮合酶(iNOS)mRNA的表达。
腹腔注射LPS(0.01 - 1.0 mg/kg)或SNAP(0.37 - 3.0 mg/kg)可剂量依赖性地预防乙醇诱导的黏膜损伤,这些保护作用伴随着GBF的显著增加和NO的过度黏膜释放。静脉注射NG-硝基-L-精氨酸甲酯(L-NAME)(20mg/kg)或腹腔注射L-NG-(1-亚氨基乙基)-赖氨酸(L-NIL)(30mg/kg)抑制NOS活性以及地塞米松(2 mg/kg腹腔注射)处理诱导NOS,均可逆转LPS的保护和充血作用,L-NAME的这种逆转作用可通过添加NOS底物L-精氨酸而显著拮抗,但不能被D-精氨酸拮抗。LPS和SNAP均显著增加PGE2的生成,而L-NAME、L-NIL或地塞米松预处理可降低这种作用。RT-PCR在完整黏膜中检测到cNOS的表达,但在LPS处理的大鼠黏膜中检测到cNOS和iNOS表达的强烈信号。
与化学NO供体SNAP类似,肠外给予LPS可通过激活精氨酸-NO系统介导的GBF增加以及可能增强的PGE2生成,保护胃黏膜免受乙醇诱导的损伤。